secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2023-03-30T23:59:59+00:00
Accession:  0001493152-23-009606
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech appoints Nancy Bryan to Board effective March 28, 2023
---------------------------------------------------------------------

- Nancy Bryan appointed to Board of Directors effective March 28, 2023; also named to Audit, Corporate Governance and Nomination, and Executive Committees.
- Bryan is President and CEO of BioFlorida with 25 years of life sciences experience including roles at Merck, GlaxoSmithKline, and Bayer.
- Board determined Bryan meets independence standards; she has no material interest in any related-party transactions.
- Bryan's appointment adds commercial and marketing expertise as AIM advances Ampligen toward late-stage development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315223009606/0001493152-23-009606-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315223009606/fom8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-009606

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer